"Designing Growth Strategies is in our DNA"

Immunoglobulin Market Size, Share & Industry Analysis, By Route of Administration (Intravenous and Subcutaneous), By Indication (Primary Immunodeficiency, Secondary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy, Guillain-Barré Syndrome, Immune Thrombocytopenic Purpura, Multifocal Motor Neuropathy, and Others), By Form (Liquid and Lyophilized), By End-user (Hospitals, Clinics, and Homecare), and Regional Forecast, 2024-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI100571

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Pipeline Analysis, by Key Players
    2. Key Industry Developments, Mergers, Acquisitions, etc.
    3. Overview of Regulatory Scenario by Key Regions
    4. Prevalence of Primary Immunodeficiency (PID), for Key Countries, 2023
    5. Impact of COVID-19 on Global Immunoglobulin Market
  5. Global Immunoglobulin Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Route of Administration
      1. Intravenous
      2. Subcutaneous
    2. Market Analysis, Insights and Forecast – By Indication
      1. Primary Immunodeficiency
      2. Secondary Immunodeficiency
      3. Chronic Inflammatory Demyelinating Polyneuropathy
      4. Guillain-Barré Syndrome
      5. Immune Thrombocytopenic Purpura
      6. Multifocal Motor Neuropathy
      7. Others
    3. Market Analysis, Insights and Forecast – By Form
      1. Liquid
      2. Lyophilized
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Clinics
      3. Homecare
    5. Market Analysis, Insights and Forecast – By Geography
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Immunoglobulin Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Route of Administration
      1. Intravenous
      2. Subcutaneous
    2. Market Analysis, Insights and Forecast – By Indication
      1. Primary Immunodeficiency
      2. Secondary Immunodeficiency
      3. Chronic Inflammatory Demyelinating Polyneuropathy
      4. Guillain-Barré Syndrome
      5. Immune Thrombocytopenic Purpura
      6. Multifocal Motor Neuropathy
      7. Others
    3. Market Analysis, Insights and Forecast – By Form
      1. Liquid
      2. Lyophilized
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Clinics
      3. Homecare
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Immunoglobulin Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Route of Administration
      1. Intravenous
      2. Subcutaneous
    2. Market Analysis, Insights and Forecast – By Indication
      1. Primary Immunodeficiency
      2. Secondary Immunodeficiency
      3. Chronic Inflammatory Demyelinating Polyneuropathy
      4. Guillain-Barré Syndrome
      5. Immune Thrombocytopenic Purpura
      6. Multifocal Motor Neuropathy
      7. Others
    3. Market Analysis, Insights and Forecast – By Form
      1. Liquid
      2. Lyophilized
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Clinics
      3. Homecare
    5. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Immunoglobulin Market Analysis, Insights and Forecast, 2019-2032
      1. Market Analysis, Insights and Forecast – By Route of Administration
      2. Intravenous
      3. Subcutaneous
    1. Market Analysis, Insights and Forecast – By Indication
      1. Primary Immunodeficiency
      2. Secondary Immunodeficiency
      3. Chronic Inflammatory Demyelinating Polyneuropathy
      4. Guillain-Barré Syndrome
      5. Immune Thrombocytopenic Purpura
      6. Multifocal Motor Neuropathy
      7. Others
    2. Market Analysis, Insights and Forecast – By Form
      1. Liquid
      2. Lyophilized
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Clinics
      3. Homecare
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Immunoglobulin Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Route of Administration
      1. Intravenous
      2. Subcutaneous
    2. Market Analysis, Insights and Forecast – By Indication
      1. Primary Immunodeficiency
      2. Secondary Immunodeficiency
      3. Chronic Inflammatory Demyelinating Polyneuropathy
      4. Guillain-Barré Syndrome
      5. Immune Thrombocytopenic Purpura
      6. Multifocal Motor Neuropathy
      7. Others
    3. Market Analysis, Insights and Forecast – By Form
      1. Liquid
      2. Lyophilized
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Clinics
      3. Homecare
    5. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Immunoglobulin Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Route of Administration
      1. Intravenous
      2. Subcutaneous
    2. Market Analysis, Insights and Forecast – By Indication
      1. Primary Immunodeficiency
      2. Secondary Immunodeficiency
      3. Chronic Inflammatory Demyelinating Polyneuropathy
      4. Guillain-Barré Syndrome
      5. Immune Thrombocytopenic Purpura
      6. Multifocal Motor Neuropathy
      7. Others
    3. Market Analysis, Insights and Forecast – By Form
      1. Liquid
      2. Lyophilized
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Clinics
      3. Homecare
    5. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. South Africa
      2. GCC
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2023)
    2. Company Profiles
      1. Shire
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. CSL Behring
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Grifols, S.A.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Kedrion S.p.A
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Octapharma
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Bio Products Laboratory Ltd.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Biotest AG
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. China Biologic Products Holdings, Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      9. LFB Group
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      10. Shanghai RAAS Blood Products Co., Ltd.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
Read Less

Figure 1: Global Immunoglobulin Market Revenue Breakdown (USD billion, %) by Region, 2023 & 2032

Figure 2: Global Immunoglobulin Market Value Share (%), by Route of Administration, 2023 & 2032

Figure 3: Global Immunoglobulin Market Value Share (%), by Indication, 2023 & 2032

Figure 4: Global Immunoglobulin Market Value Share (%), by Form, 2023 & 2032

Figure 5: Global Immunoglobulin Market Value Share (%), by End-user, 2023 & 2032

Figure 6: Global Immunoglobulin Market Value (USD billion), by Region, 2023 & 2032

Figure 7: North America Immunoglobulin Market Value (USD billion), by Route of Administration, 2023 & 2032

Figure 8: North America Immunoglobulin Market Value Share (%), by Route of Administration, 2023

Figure 9: North America Immunoglobulin Market Value (USD billion), by Indication, 2023 & 2032

Figure 10: North America Immunoglobulin Market Value Share (%), by Indication, 2023

Figure 11: North America Immunoglobulin Market Value (USD billion), by Form, 2023 & 2032

Figure 12: North America Immunoglobulin Market Value Share (%), by Form, 2023

Figure 13: North America Immunoglobulin Market Value (USD billion), by End-user, 2023 & 2032

Figure 14: North America Immunoglobulin Market Value Share (%), by End-user, 2023

Figure 15: North America Immunoglobulin Market Value (USD billion), By Country, 2023 & 2032

Figure 16: North America Immunoglobulin Market Value Share (%), By Country, 2023

Figure 17: Europe Immunoglobulin Market Value (USD billion), by Route of Administration, 2023 & 2032

Figure 18: Europe Immunoglobulin Market Value Share (%), by Route of Administration, 2023

Figure 19: Europe Immunoglobulin Market Value (USD billion), by Indication, 2023 & 2032

Figure 20: Europe Immunoglobulin Market Value Share (%), by Indication, 2023

Figure 21: Europe Immunoglobulin Market Value (USD billion), by Form, 2023 & 2032

Figure 22: Europe Immunoglobulin Market Value Share (%), by Form, 2023

Figure 23: Europe Immunoglobulin Market Value (USD billion), by End-user, 2023 & 2032

Figure 24: Europe Immunoglobulin Market Value Share (%), by End-user, 2023

Figure 25: Europe Immunoglobulin Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 26: Europe Immunoglobulin Market Value Share (%), By Country/ Sub-region, 2023

Figure 27: Asia Pacific Immunoglobulin Market Value (USD billion), by Route of Administration, 2023 & 2032

Figure 28: Asia Pacific Immunoglobulin Market Value Share (%), by Route of Administration, 2023

Figure 29: Asia Pacific Immunoglobulin Market Value (USD billion), by Indication, 2023 & 2032

Figure 30: Asia Pacific Immunoglobulin Market Value Share (%), by Indication, 2023

Figure 31: Asia Pacific Immunoglobulin Market Value (USD billion), by Form, 2023 & 2032

Figure 32: Asia Pacific Immunoglobulin Market Value Share (%), by Form, 2023

Figure 33: Asia Pacific Immunoglobulin Market Value (USD billion), by End-user, 2023 & 2032

Figure 34: Asia Pacific Immunoglobulin Market Value Share (%), by End-user, 2023

Figure 35: Asia Pacific Immunoglobulin Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 36: Asia Pacific Immunoglobulin Market Value Share (%), By Country/ Sub-region, 2023

Figure 37: Latin America Immunoglobulin Market Value (USD billion), by Route of Administration, 2023 & 2032

Figure 38: Latin America Immunoglobulin Market Value Share (%), by Route of Administration, 2023

Figure 39: Latin America Immunoglobulin Market Value (USD billion), by Indication, 2023 & 2032

Figure 40: Latin America Immunoglobulin Market Value Share (%), by Indication, 2023

Figure 41: Latin America Immunoglobulin Market Value (USD billion), by Form, 2023 & 2032

Figure 42: Latin America Immunoglobulin Market Value Share (%), by Form, 2023

Figure 43: Latin America Immunoglobulin Market Value (USD billion), by End-user, 2023 & 2032

Figure 44: Latin America Immunoglobulin Market Value Share (%), by End-user, 2023

Figure 45: Latin America Immunoglobulin Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 46: Latin America Immunoglobulin Market Value Share (%), By Country/ Sub-region, 2023

Figure 47: Middle East & Africa Immunoglobulin Market Value (USD billion), by Route of Administration, 2023 & 2032

Figure 48: Middle East & Africa Immunoglobulin Market Value Share (%), by Route of Administration, 2023

Figure 49: Middle East & Africa Immunoglobulin Market Value (USD billion), by Indication, 2023 & 2032

Figure 50: Middle East & Africa Immunoglobulin Market Value Share (%), by Indication, 2023

Figure 51: Middle East & Africa Immunoglobulin Market Value (USD billion), by Form, 2023 & 2032

Figure 52: Middle East & Africa Immunoglobulin Market Value Share (%), by Form, 2023

Figure 53: Middle East & Africa Immunoglobulin Market Value (USD billion), by End-user, 2023 & 2032

Figure 54: Middle East & Africa Immunoglobulin Market Value Share (%), by End-user, 2023

Figure 55: Middle East & Africa Immunoglobulin Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 56: Middle East & Africa Immunoglobulin Market Value Share (%), By Country/ Sub-region, 2023

Figure 57: Global Immunoglobulin Market Share (%), By Company, 2023

Table 1: Global Immunoglobulin Market Revenue (USD billion) Forecast, by Route of Administration, 2019–2032

Table 2: Global Immunoglobulin Market Revenue (USD billion) Forecast, by Indication, 2019–2032

Table 3: Global Immunoglobulin Market Revenue (USD billion) Forecast, by Form, 2019–2032

Table 4: Global Immunoglobulin Market Revenue (USD billion) Forecast, by End-user, 2019–2032

Table 5: Global Immunoglobulin Market Revenue (USD billion) Forecast, by Region, 2019-2032

Table 6: North America Immunoglobulin Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 7: North America Immunoglobulin Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 8: North America Immunoglobulin Market Revenue (USD billion) Forecast, by Form, 2019-2032

Table 9: North America Immunoglobulin Market Revenue (USD billion) Forecast, by End-user, 2019-2032

Table 10: North America Immunoglobulin Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 11: Europe Immunoglobulin Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 12: Europe Immunoglobulin Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 13: Europe Immunoglobulin Market Revenue (USD billion) Forecast, by Form, 2019-2032

Table 14: Europe Immunoglobulin Market Revenue (USD billion) Forecast, by End-user, 2019-2032

Table 15: Europe Immunoglobulin Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 16: Asia Pacific Immunoglobulin Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 17: Asia Pacific Immunoglobulin Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 18: Asia Pacific Immunoglobulin Market Revenue (USD billion) Forecast, by Form, 2019-2032

Table 19: Asia Pacific Immunoglobulin Market Revenue (USD billion) Forecast, by End-user, 2019-2032

Table 20: Asia Pacific Immunoglobulin Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 21: Latin America Immunoglobulin Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 22: Latin America Immunoglobulin Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 23: Latin America Immunoglobulin Market Revenue (USD billion) Forecast, by Form, 2019-2032

Table 24: Latin America Immunoglobulin Market Revenue (USD billion) Forecast, by End-user, 2019-2032

Table 25: Latin America Immunoglobulin Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 26: Middle East & Africa Immunoglobulin Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 27: Middle East & Africa Immunoglobulin Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 28: Middle East & Africa Immunoglobulin Market Revenue (USD billion) Forecast, by Form, 2019-2032

Table 29: Middle East & Africa Immunoglobulin Market Revenue (USD billion) Forecast, by End-user, 2019-2032

Table 30: Middle East & Africa Immunoglobulin Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Immunoglobulins Market Size, Share and Global Industry Trend Forecast till 2032
  • 2019-2032
  • 2023
  • 2019-2022
  • 160
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase